This compound is primarily utilized as a key intermediate in the synthesis of various pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs). Its structure, featuring a trifluoromethyl group and a piperazine ring, makes it valuable for creating molecules with enhanced biological activity and metabolic stability. It is often employed in the production of drugs targeting central nervous system disorders, such as antidepressants and antipsychotics, due to its ability to modulate receptor interactions. Additionally, its tert-butyl carboxylate group provides a protective function during synthetic processes, allowing for selective reactions in complex multi-step syntheses. The trifluoromethyl group further contributes to the lipophilicity and bioavailability of the final drug molecules, making it a crucial component in medicinal chemistry.